# Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis

> **NCT07103863** · — · ENROLLING_BY_INVITATION · sponsor: **Beijing Anzhen Hospital** · enrollment: 49 (estimated)

## Conditions studied

- AL Amyloidosis (AL)
- Cardiac Amyloidosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07103863
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-02-13
- **Primary completion:** 2028-02-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07103863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07103863, "Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07103863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*